- Filed
- Mar 17, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | FY 2024 · Dec 31, 2023 | 48.83M sh |
| Capex | FY 2024 · Dec 31, 2023 | $42.97K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$614.53K |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $36.47K |
| Cash And Equivalents restated | FY 2024 · Dec 31, 2022 | $20.62K |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $3.35M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $3.67M |
| Current Assets | FY 2024 · Dec 31, 2023 | $68.16K |
| Total Assets | FY 2024 · Dec 31, 2023 | $1.42M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$0.03 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$0.03 |
| Rd Expense | FY 2024 · Dec 31, 2023 | $101.41K |
| Net Income | FY 2024 · Dec 31, 2023 | −$1.7M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$1.63M |
| Gross Profit | FY 2024 · Dec 31, 2023 | −$265.64K |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $324.04K |
| Revenue | FY 2024 · Dec 31, 2023 | $192.18K |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | −$545.38K |